T he microRNAs miR-144 and -451 are encoded by a bicistronic gene that is strongly induced during red blood cell formation (erythropoiesis). Ablation of the miR-144/451 gene in mice causes mild anemia under baseline conditions. Here we show that miR-144/451 -/-erythroblasts exhibit increased apoptosis during recovery from acute anemia. Mechanistically, miR-144/451 depletion increases the expression of the miR-451 target mRNA Cab39, which encodes a co-factor for the serine-threonine kinase LKB1. During erythropoietic stress, miR-144/451 -/-erythroblasts exhibit abnormally increased Cab39 protein, which activates LKB1 and its downstream AMPK/mTOR effector pathway. Suppression of this pathway via drugs or shRNAs enhances survival of the mutant erythroblasts. Thus, miR-144/451 facilitates recovery from acute anemia by repressing Cab39/AMPK/mTOR. Our findings suggest that miR-144/451 is a key protector of erythroblasts during pathological states associated with dramatically increased erythropoietic demand, including acute blood loss and hemolytic anemia. 
Introduction
Dysregulation of microRNAs (miRNAs) is implicated in the pathophysiology of many human diseases including cancer, cardiovascular disease, and anemia. 1, 2 There is increasing evidence that miRNAs regulate red blood cell (RBC) formation (erythropoiesis) by controlling the proliferation and differentiation of RBC precursors, termed erythroblasts. 3 For example, miR-126 negatively regulates erythropoiesis by repressing mRNA encoding the tyrosine phosphatase PTPN9, which is required for erythroblast proliferation, 4 whereas ectopic expression of miR-27a, miR-24, and miR-146b in CD34
+ hematopoietic progenitor cells promotes erythroid maturation by repressing GATA-2 or increasing GATA-1, which activates the GATA switch, a key step in erythropoiesis. 5, 6 However, the role of miRNAs and their targets in regulating erythropoiesis is not fully understood.
The bicistronic miRNA locus encoding miRs-144 and -451 is strongly induced during erythropoiesis in zebrafish, mice, and humans. [7] [8] [9] Chromatin immunoprecipitation (ChIP) and gene complementation studies show that miR-144/451 transcription is activated by GATA-1, 10 a transcription factor that regulates many aspects of erythropoiesis, including precursor proliferation, maturation, and survival. Remarkably, miR-451 accounts for approximately 50% of the total miRNA pool in mouse fetal liver (FL) erythroblasts. 11 Unlike most miRNAs, miR-451 biogenesis occurs independently of the RNA III enzyme Dicer. Rather, it is Argonaut 2 (Ago2) that catalyzes the cleavage of pre-miR-451 hairpins. 12 Inhibition of miR-144/451 blocks erythropoiesis in tissue culture models. 8, 10, [13] [14] [15] Fewer studies have been performed with in vivo models. [13] [14] [15] Moreover, the phenotypes observed after manipulating miR-144/451 expression vary according to the model used and the mode of gene manipulation. For example, miR-144/451 inhibition appears to exert a greater effect on erythroblasts in culture than on those in vivo, suggesting that the phenotype depends on the cell environment (X Fang et al., unpublished data, 2017) . Along with others, we have also demonstrated that miR-144/451 gene knockout (KO) mice exhibit mild baseline anemia that worsens upon oxidative stress. 13, 15 Similarly, loss of miR-451 in zebrafish renders erythroid precursors sensitive to oxidant stress. 15 The anti-oxidant role of miR-144/451 during erythropoiesis is at least partially dependent on suppression of the mRNA target Ywhaz, which encodes the cytoplasmic adaptor protein 14-3-3ζ. 13 We discovered that erythroblasts isolated from miR-144/451 −/− FL during embryonic gestation or bone marrow and spleen during acute anemia exhibit increased apoptosis compared to wild-type (WT) counterparts. This effect is mediated by derepression of the direct miR-451 target mRNA Cab39 followed by activation of the downstream LKB1/AMPK/mTOR pathway. Thus, miR-144/451 enhances physiological responses to acute anemia by promoting the survival of RBC precursors.
Methods

Animals
miR-144/451 KO mice were described previously.
15 p53ER knock-in (KI) mice were kindly provided by Gerard Evan (University of Cambridge, UK).
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Cell culture and treatment G1E and G1E-ER4 erythroid cells were grown in culture as previously described. 17 The isolation of erythroid progenitors from embryonic day 14.5 (E14.5) FLs, the growth of erythroid progenitors in maturation medium, and the retroviral infection of erythroid cells in expansion medium have all been described previously. 18 Details of drug treatments of cells are described in the Online Supplementary Appendix.
Protein and miRNA expression
Western blot and real-time PCR analyses for gene expression were described in the Online Supplementary Appendix.
Fluorescence-activated cell sorting (FACS)
The expression of RBC surface markers and cell death were analyzed with an LSRII or LSRFortessa Cell Analyzer System (BD Biosciences). The Annexin V Early Apoptosis Detection Kit (cat. n. 553786) was obtained from BD Biosciences. 
Dual-luciferase reporter assay
Construction of the plasmids for luciferase assays is described in the Online Supplementary Appendix. The dual-luciferase reporter assay was performed as previously described.
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Retroviral shRNA delivery
The construction of retroviral plasmids and transduction of cells are described in the Online Supplementary Appendix.
Hematologic analysis
For hematocrit (HCT) and reticulocyte counts, blood from adult mice was sampled retro-orbitally, anticoagulated with EDTA, and analyzed on a Hemavet HV950FS analyzer (Drew Scientific, Dallas, TX, USA). Heparinized glass microhematocrit tubes (Globe Scientific, Paramus, NJ, USA) were used for manual spun hematocrits. Reticulocytes were counted using Retic-COUNT reagent (BD Biosciences) or Ter119/CD71 staining and analyzed on a FACSCalibur Flow Cytometer (BD Biosciences).
For phenylhydrazine (PHZ) treatment, mice were injected intraperitoneally (63 mg/kg). HCT and reticulocyte counts were analyzed for ten consecutive days thereafter.
To eradicate erythroid progenitors in adult mice, 5-FU (SigmaAldrich) at a single dose of 150 mg/kg was injected intraperitoneally, and the HCT and reticulocyte counts were analyzed for 25 consecutive days thereafter. Animal survival was monitored every day.
To generate acute anemia by bleeding, 400 μL of blood was drawn retro-orbitally every day. The HCT and reticulocyte counts were analyzed three days later.
Microarray analysis
CD71
+ /Ter119 + /FSC high nucleated bone marrow cells from miR-144/451 −/− mice and WT controls were purified by flow cytometry, and samples were processed for microarray analysis using the GeneChip Mouse Genome 430 2.0 Array (Affymetrix), as described previously. 15 The database for G1E-ER4 erythroid maturation has been described in an earlier paper.
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Statistical analysis
Statistical analyses were performed using Microsoft Office Excel 2011 (Microsoft Corporation, Redmond, WA, USA). Graphs were created using Adobe Photoshop CS6 (Adobe Systems Inc., San Jose, CA, USA). Data from triplicate experiments or 3 different samples are presented as the mean ± standard deviation. The differences were assessed by two-tailed Student t-tests. P<0.05 was considered statistically significant. All experiments were repeated at least 3 times.
Results
Increased apoptosis of miR-144/451
−/− erythroblasts during erythropoietic stress Figure S1A and B). Fetal liver erythropoiesis is considered a "stress state" because production demands are extremely high compared to steady state bone marrow erythropoiesis in adults. 20 Thus, miR-144/451 may protect erythroblasts from apoptosis during erythropoietic stress associated with increased demands for RBC production. Consistent with this, we had previously noted that recovery from (Figure 2A) , which was associated with a greater decline in their hematocrit ( Figure 2B ). During the recovery phase after 5-FU treatment, the mutant mice exhibited higher levels of late stage circulating erythroid precursors (reticulocytes) (Figure 2C ), probably in response to the more severe anemia ( Figure 2B) . However, the time to maximal reticulocyte response was delayed by several days in KO mice compared to WT controls ( Figure 2C) . Similarly, the emergence of bone marrow erythroid precursors was delayed in KO mice ( Figure 2D-G) . Moreover, bone marrow erythroblasts of miR-144/451 −/− mice with 5-FU treatment exhibited increased apoptosis compared to WT controls ( Figure 2H and I). We also observed increased apoptosis of miR-144/451 −/− bone marrow and splenic erythroblasts during recovery from PHZ-induced anemia ( Figure 3A and B) or phlebotomy ( Figure 3C and D 
miR-451 targets Cab39 mRNA in erythroblasts
Several mRNAs previously identified as miR-451 target mRNAs, including Myc, Ywhaz/14-3-3ζ, and Cab39 ( Figure 4A ), encode general regulators of cell survival, proliferation, and maturation. 13, 15, 21 Cab39 is an obligatory cofactor for the serine/threonine kinase LKB1, a tumor suppressor that regulates responses to metabolic stress, in part by activating AMP-activated protein kinase (AMPK). 22 miR-451 drives human glioma cell expansion by inhibiting this pathway via direct repression of Cab39. 21 (Figure 5A) . 22, 23 Of note, LKB1 and AMPK mRNAs are up-regulated during normal mouse and human erythroid maturation (Online Supplementary Figure S2A-E) . 19, 24 Cab39 was up-regulated in cultured miR-144/451 −/− FL erythroblasts compared to controls ( Figures 4D and 5B and C). These cells also exhibited strongly increased phosphorylation of AMPK at Thr172, and to a lesser extent, upregulation of total AMPK protein ( Figure 5B and D) . AMPK can inhibit the mTOR pathway to inhibit cell growth and either induce or suppress apoptosis, depending on cellular context. 25 To investigate this mechanism in miR-144/451 −/− erythroblasts, we performed Western blot studies to interrogate upstream and downstream effectors. 26, 27 miR-144/451 −/− FL erythroblasts grown in culture exhibited elevated phospho-Raptor and phospho-TSC2, along with reduced phosphorylation of p70S6K, S6, and eIF4B ( Figure 5B and E-I), consistent with suppression of the mTOR by activated AMPK ( Figure 5A ). We observed similar patterns in primary erythroblasts from E14.5 FLs (Online Supplementary Figure S3) . Together, these findings indicate that the loss of miR-144/451 during FL erythropoiesis derepresses the miR-451 target Cab39, resulting in mTOR repression.
Attenuation of Cab39/AMPK/mTOR signaling rescues erythroid apoptosis after miR-144/451 depletion
To determine whether miR-144/451 regulates survival of FL erythroblasts via Cab39/AMPK/mTOR, we designed shRNA-expressing retroviruses to knock down components of this pathway. We grew FL erythroblasts in expansion medium, infected them with individual shRNA retroviruses, induced erythroid maturation for 24 h, and then examined apoptosis in the cells. Inhibiting Figure S4A and B) . Conversely, inhibiting mTOR activity with rapamycin or activating AMPK with AICAR induced apoptosis in WT erythroblasts (Online Supplementary Figure  S4C-F) . Overall, our results with shRNAs and pharmacological inhibitors indicate that miR-451 facilitates fetal erythroblast survival by inhibiting expression of Cab39, resulting in suppression of LKB1 and AMPK and activation of the downstream mTOR pathway.
The increased apoptosis of miR-144/451 −/− erythroblasts is p53-dependent
Depending on cell context, mTOR can regulate p53 positively or negatively to alter rates of apoptosis. [28] [29] [30] Thus, we investigated p53 levels and effector functions in miR-144/451 −/− erythroblasts that exhibit reduced mTOR activity. p53 level was increased in miR-144/451 −/− E14.5 FL erythroblasts ( Figure 7A ). To investigate the functional implications of this finding, we crossed miR-144/451 −/− mice with "p53 knock-in (KI)" mice, in which both alleles of the normal p53 gene are replaced by a cDNA encoding a 4-hydroxytamoxifen (4-OHT)-dependent form of the fusion protein, p53-estrogen receptor. 16, 31 There is a lack of endogenous p53 activity in the p53 KI mice unless 4-OHT is applied. In the absence of 4-OHT, loss of p53 function rescued the deficient erythroblast numbers in E14. 
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haematologica | 2018; 103(3) Figure 5 . Activation of the Cab39/AMPK/mTOR pathway in miR-144/451 −/− erythroblasts. (A) Schematic illustration of the major signaling components in the Cab39/AMPK/mTOR molecular pathway. Cab39 expression leads to increased LKB1 activity in the Cab39/LKB1/STRAD protein complex, which activates its substrate AMPK. AMPK activation is vital for modulation of the mTOR signaling cascade and for potential stabilization of p53 activity, which subsequently governs the fate of the target cells, including their apoptosis, survival, and/or proliferation. (B) Western blot analysis of the expression of Cab39, p-AMPKα, p-Raptor, p-TSC2, p-p70S6K, p-S6, and p-eIF4B, along with their non-phosphorylated counterparts, in fetal liver (FL) erythroblasts grown in maturation medium for 24 hours, when all the cells were nucleated erythroblasts. 14-3-3ζ was used as a positive control, and actin was used as a sample loading control. Quantitative analyses of the protein intensity are shown in (C-I) as follows: 21 Thus, miR-451 may employ a common pathway to regulate stress responses in different cell types, but the net effects are context-dependent. During erythropoiesis, mTOR activity is relatively high, and the pathway appears to exert a positive effect on precursor expansion and protection against erythropoietic stress, 32 consistent with the current study.
Contrasting effects of AMPK activity on apoptosis have been observed during various cellular stresses. 25 In some cases, AMPK functions to balance cellular redox state and promote survival during metabolic or genotoxic stress. 33, 34 In other cases, AMPK activation during stress causes increased apoptosis. 35, 36 In this study, we showed that in 
miR-144/451
−/− erythroblasts, AMPK is activated by overexpressed Cab39 and promotes apoptosis by inhibiting mTOR activity. It is unclear how levels of stress affect the regulatory role of AMPK in apoptosis, i.e. does AMPK favor cell survival under mild stress but enhance apoptosis under severe stress?
In this study, we found that loss of miR-144/451 induces apoptosis in a p53-dependent fashion. Some evidence from a study in Diamond-Blackfan anemia (DBA) has shown that haploinsufficiency of ribosomal protein subunits can induce erythroblast apoptosis via p53-dependent mechanisms. 37 Stabilization of p53 by the MDM2 antagonist SAR405838 induces major hematopoietic defects including erythroid precursor apoptosis in vitro. 38 How p53 is activated after miR-144/451 depletion remains to be elucidated. In some cell types, AMPK induces apoptosis by activating p53 through phosphorylation, 34, 35 whereas others have reported that p53 activates AMPK/mTOR signaling to suppress cell growth by targeting sestrin 1 and sestrin 2 upon stress. 39 In addition, several groups report an inhibitory role of mTOR activity on p53 function. 28, 29 It is possible that a positive feedback loop involving AMPK, p53, and mTOR signaling regulates apoptosis of miR-144/451 −/− erythroid cells under stress conditions, although further investigations are required to fully define the process.
Anemia is a common complication after orthotopic kidney transplantation due to multifactorial effects including iron deficiency, reduced erythropoietin production, and chronic or acute inflammation. Additionally, mTOR inhibition by sirolimus is a possible risk factor for the development of anemia in kidney transplant recipients. 40, 41 There is also a substantial risk of anemia from the mTOR inhibitor everolimus in cancer therapy. 42 Interestingly, studies in animal models and cell cultures demonstrate that treatment with mTOR inhibitors reduces RBC size, independent of alterations in kidney function. 32, 43 Consistent with this finding, miR-144/451 −/− mice exhibit microcytic anemia, 15 perhaps due to mTOR inhibition. Moreover, the current study shows that these mice exhibit enhanced erythroblast apoptosis with various erythropoietic stresses including developmental expansion of FL, hemolysis, acute blood loss, and precursor depletion by 5-FU, a chemotherapeutic drug. Accelerated apoptosis in the absence of miR-144/451 is caused by overexpression of the miR-451 target Cab39, which activates AMPK, thus inhibiting mTOR signaling. Therefore, our data explain why erythroid apoptosis is an underlying mechanism of profound anemia when the enzymatic activity of Cab39/LKB1/AMPK is significantly increased and mTOR signaling is perturbed.
A mechanistic understanding of the differences between steady state and stress erythropoiesis could be of benefit in multiple clinical settings. 44 Moreover, these processes are likely to be impacted differently by various disease states. Common causes of acquired anemia include dietary iron deficiency, malaria, chronic infectious diseases, autoimmune or rheumatological disorders, chemotherapy, and chronic kidney disease. Genetic causes of anemia include DBA and hemoglobinopathies such as sickle cell disease (SCD) and thalassemia. 45 Of note,
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414 haematologica | 2018; 103(3) while numerous studies, including the current one, reveal a positive effect of mTOR on erythropoiesis, other studies show that mTOR inhibition may have beneficial effects in some forms of anemia including SCD and thalassemia, 46, 47 again emphasizing context-or disease-dependent functions for this pathway. Our mouse model makes it possible to investigate further the roles of miR-144/451, including its effects on mTOR, in physiological adaptations to various red cell disorders.
miR-144/451 is a bicistronic gene whose expression is directly controlled by GATA1 in erythroid cells. 10, 15 Interestingly, our research and that of others had previously observed that: 1) miR-144 level is always lower than miR-451 level in both fetal and adult erythroid cells; 10, 14 and 2) the expression of miR-144 is ubiquitous whereas the expression of miR-451 is much more constrained in hematopoietic compartments during embryonic development. 48, 49 These data suggest that overlapping and independent mechanisms regulate the differential expression of miR-144 and miR-451. The current study focuses on an miR-451-dependent mechanism for regulating stress erythropoiesis. However, it is not clear whether miR-144 impacts this process. Of note, suppression of miR-144 inhibits erythropoiesis in cultured human CD34 + cells. 50 In future studies, it will be interesting to investigate the effects of miR-144 and miR-451 on erythropoiesis separately by examining mice that harbor single miR-specific mutations.
